New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting
Links shared publicly online about this topic.
- 1,146total visits
New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting
Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.
View full resource at news-medical.net
Tags: ADHD, ADHD Medication, Disease and Condition, Intuniv, Shire
Most Recently Shared on May 24, 2010 at 9:05 am By:
New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting: Shire plc, the global spe... http://bit.ly/d1slqM
Advertisement
